##印度制药厂爆炸致17死数十伤，疑似电力故障引发
**中新网8月22日电** 据《印度时报》、《印度教徒报》等媒体报道，当地时间21日，印度东南部安得拉邦一家制药厂发生爆炸并引发火灾，已造成17人死亡，另有数十人受伤。
据报道，当天下午约2点，安得拉邦一家制药厂发生爆炸起火。爆炸的冲击力非常强烈，现场浓烟滚滚，火光冲天。当地官员维贾亚·克里希南表示，此次事故并非由化学装置爆炸引起，而是疑似电力故障引发。此前有媒体报道称，起火是由于该厂一个化学反应装置爆炸所致，但这一说法已被当地官员否认。
报道称，制药厂分两班运营，共有381名员工。大火发生在午餐期间，因此，员工在场较少。目前，约有30名伤者被转移到当地医院，接受治疗。被困在制药厂的13人也已获救。
印度政府已启动调查，以查明事故原因并追究责任。此次事故再次引发了人们对印度制药行业安全问题的关注。近年来，印度制药行业发展迅速，但安全问题也日益突出。
据悉，印度制药行业是全球最大的仿制药生产基地之一，其产品出口到全球100多个国家和地区。近年来，印度制药行业发生了多起安全事故，包括爆炸、火灾、中毒等，造成人员伤亡和财产损失。
专家表示，印度制药行业的安全问题主要与以下因素有关：
* **监管不力:** 印度制药行业监管体系存在漏洞，一些企业存在安全隐患，但未得到及时整改。
* **安全意识薄弱:** 一些企业安全意识薄弱，对安全生产重视不够，导致安全事故频发。
* **技术水平落后:** 一些企业技术水平落后，设备老化，存在安全隐患。
印度政府已采取措施加强制药行业安全监管，但要彻底解决安全问题，还需要企业加强安全管理，提高安全意识，并不断提升技术水平。
英语如下：
##India: 17 Dead, Dozens Injured in Pharmaceutical Plant Explosion
**Keywords:** India, explosion, casualties
**Content:**
A pharmaceuticalplant in Andhra Pradesh, southeastern India, exploded and caught fire on Monday, killing 17 people and injuring dozens more, according to reports from the Times ofIndia and The Hindu.
The explosion occurred around 2 p.m. local time, sending shockwaves through the area and creating a massive plume of smokeand flames. Local official Vijaya Krishnan said the incident was not caused by a chemical explosion but was likely triggered by an electrical fault. Earlier reports suggested a chemical reaction vessel had exploded, but this was denied by local officials.
The plantoperates in two shifts with a total of 381 employees. The fire broke out during lunch break, meaning fewer employees were present. Approximately 30 injured individuals have been transported to local hospitals for treatment, and 13people trapped in the plant have been rescued.
The Indian government has launched an investigation to determine the cause of the accident and hold those responsible accountable. The incident has once again raised concerns about safety issues within India’s pharmaceutical industry.
In recent years, India’s pharmaceutical industry has experienced rapid growth, but safetyconcerns have also become increasingly prominent.
India is one of the world’s largest producers of generic drugs, exporting its products to over 100 countries. In recent years, the industry has witnessed numerous safety incidents, including explosions, fires, and poisonings, resulting in casualties and property damage.
Experts have attributed the safety issues in the Indian pharmaceutical industry to several factors:
* **Lax Regulation:** The regulatory system for the Indian pharmaceutical industry has loopholes, allowing some companies with safety hazards to operate without timely rectification.
* **Weak Safety Awareness:** Some companies have a weak safety consciousness and prioritize production over safety,leading to frequent accidents.
* **Outdated Technology:** Some companies have outdated technology and aging equipment, posing safety risks.
The Indian government has taken steps to strengthen safety regulations in the pharmaceutical industry, but a complete resolution of safety issues requires companies to enhance safety management, raise safety awareness, and continuously improve their technological capabilities.
【来源】http://www.chinanews.com/gj/2024/08-22/10272682.shtml
Views: 2